公司概覽
業務類別 --
業務概覽 Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.
公司地址 117 Camberwell Road, Suite 1.01, Hawthorn East, Melbourne, VIC, AUS, 3123
電話號碼 +61 390920480
傳真號碼 --
公司網頁 https://www.neurenpharma.com
員工數量 11
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jonathan Pilcher Director, Chief Executive Officer and Managing Director -- 24/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Dianne Angus Independent Director 24/04/2026
Mr. Patrick Donald Davies, M.B.A. Non-Executive Chairman of the Board 24/04/2026
Mr. Jonathan Pilcher Director, Chief Executive Officer and Managing Director 24/04/2026
Dr. Jenny Harry Independent Director 24/04/2026
Mr. Joe Basile Independent Director 24/04/2026
 
所屬ETF (更新日期: 14/11/2026 02:44)
代號 名稱 佔比% ▼ 持有日期
DDLSWisdomTree Dynamic Intl SmCap Eq ETF0.01%30/10/2026
DWMWisdomTree International Equity ETF0.01%30/10/2026
WSMLiShares MSCI World Small-Cap ETF0.01%30/10/2026
DFSIDimensional International Sstby Cr 1 ETF0.005%30/10/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.004%30/10/2026
PEPTREX Peptide ETF0.002%30/10/2026
ASDDefiance Autism Impact ETF0.002%30/10/2026
DXIVDimensional International Vector Eq ETF0.002%30/10/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%30/10/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF<0.000001%21/09/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.